Interested in becoming a first movers into this valuable marketplace?
Feldan Bio offers Full Technology Transfer of its Technologies for industrial production of biogeneric therapeutic proteins for the treatment of various diseases including cancer, diabetes, hepatitis or multiple sclerosis. The Technologies are mainly addressed to pharmaceutical companies in emerging markets with unmet medical needs.
Our Technology Transfer packages include a comprehensive course at our facility. During the training our qualified scientists and engineers show you how to develop simple, cost effective and easy to implement proprietary technology for the production of highly active bulk recombinant E.Coli derived proteins. Each batch production at our facility is within 2-3 days and can yield 1000-2000 mg/protein
The Technologies offered by Feldan Bio allow industry newcomers to manufacture and commercialize high-quality Biopharmaceuticals locally and low-cost and quickly acquire a clear edge over the competition resulting from low production costs, high yield and production efficiency. For the local consumers, this also provide affordable treatment and cures that increase life expectancy and enhance life
Other Technologies can also be available upon request.
For more technology offers, additional information on our Technology Transfer Packages or to request a Brochure, do not hesitate to contact our Technology Transfer Specialists at info@feldan-bio.com
Your basket is empty.
